Study Finds Biological Explanation for Racial Disparities in Survival for Certain Cancers January 25, 2017Vol.40 No.01
Drugs & Targets Tecentriq receives priority review for treatment of urothelial carcinoma January 25, 2017Vol.40 No.01
NewVac Meets Primary Endpoints in Phase II Trial of Quisinostat Combination in Platinum-Resistant Disease January 25, 2017Vol.40 No.01
MammaPrint Substantially Impacts How Breast Cancer in Germany is Treated January 25, 2017Vol.40 No.01
Guest Editorial NCI formulary, moonshot and public-private partnerships January 20, 2017Vol.43 No.03By Howard Fingert
Drugs & Targets Medicinal product designation for TB-403 for medulloblastoma January 20, 2017Vol.43 No.03
